Ernest Mario School of Pharmacy, Rutgers-The State University of NJ, Piscataway, NJ, USA.
Drug Dev Ind Pharm. 2012 Nov;38(11):1408-16. doi: 10.3109/03639045.2011.653363. Epub 2012 Feb 1.
In transdermal drug delivery systems (TDDS), it is a challenge to achieve stable and prolonged high permeation rates across skin, because the concentration of the drug dissolved in the matrix has to be high in order to maintain zero order release kinetics of the drug. In case of poorly soluble drugs, due to thermodynamic challenges, there is a high tendency for the drug to nucleate immediately after formulating or even during storage. The present study focuses on the efficiency of vitamin E TPGS/HPMC supersaturated solution and other solubilizer/polymer systems to improve the solubility of the drug and inhibit crystal growth in the transdermal formulation. Effect of several solubilizers, for example, Pluronic F-127, vitamin E TPGS and co-solvent, for example, propylene glycol (PG) were studied on the supersaturated systems of ibuprofen as model drug. Various stabilizers such as hydroxylpropyl methylcellulose (HPMC 3 cps) and polyvinylpyrrolidone (PVP K-30) were examined to evaluate their crystal inhibitory effects. Different analytical tools were used in this study to detect the growth of crystals in the systems. Vitamin E TPGS and HPMC 3 cps formulation produced the highest permeation rate of the drug as compared to other systems. In addition, the onset of crystallization time was shown to be longer with this formulation as compared to other solubilizer/polymer combinations.
在经皮给药系统(TDDS)中,实现稳定和延长药物透过皮肤的高渗透速率是一项挑战,因为为了保持药物的零级释放动力学,溶解在基质中的药物浓度必须很高。对于难溶性药物,由于热力学挑战,药物在配方后甚至在储存过程中立即成核的倾向很高。本研究专注于维生素 E TPGS/HPMC 过饱和溶液和其他增溶剂/聚合物系统的效率,以提高药物的溶解度并抑制透皮制剂中的晶体生长。研究了几种增溶剂,例如 Pluronic F-127、维生素 E TPGS 和共溶剂,例如丙二醇(PG),对布洛芬作为模型药物的过饱和系统的影响。研究了各种稳定剂,例如羟丙基甲基纤维素(HPMC 3 cps)和聚乙烯吡咯烷酮(PVP K-30),以评估它们对晶体的抑制作用。本研究使用了不同的分析工具来检测系统中晶体的生长。与其他系统相比,维生素 E TPGS 和 HPMC 3 cps 制剂产生了药物的最高渗透速率。此外,与其他增溶剂/聚合物组合相比,该制剂显示出结晶开始时间更长。